The future of pharmocotherapy for paediatric anxiety

Research output: Contribution to journalArticle

Abstract

There is a growing body of data supporting the use of pharmacological agents in the treatment of paediatric anxiety. The most compelling data exists for the use of selective serotonin re-uptake inhibitors. However, questions the safe and efficacious use of medications with anxiolytic properties still remain. Although the field has progressed in the past several years, it is evident that more research needs to be done in the future.

Original languageEnglish (US)
Pages (from-to)573-574
Number of pages2
JournalExpert Opinion on Pharmacotherapy
Volume3
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Anti-Anxiety Agents
Serotonin Uptake Inhibitors
Anxiety
Pharmacology
Pediatrics
Research

Keywords

  • Adolescent
  • Anxiety
  • Child
  • Psychopharmacology
  • Treatment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The future of pharmocotherapy for paediatric anxiety. / Findling, Robert L.

In: Expert Opinion on Pharmacotherapy, Vol. 3, No. 5, 2002, p. 573-574.

Research output: Contribution to journalArticle

@article{6322f19693e14eea892ad741c3f09c31,
title = "The future of pharmocotherapy for paediatric anxiety",
abstract = "There is a growing body of data supporting the use of pharmacological agents in the treatment of paediatric anxiety. The most compelling data exists for the use of selective serotonin re-uptake inhibitors. However, questions the safe and efficacious use of medications with anxiolytic properties still remain. Although the field has progressed in the past several years, it is evident that more research needs to be done in the future.",
keywords = "Adolescent, Anxiety, Child, Psychopharmacology, Treatment",
author = "Findling, {Robert L}",
year = "2002",
doi = "10.1517/14656566.3.5.573",
language = "English (US)",
volume = "3",
pages = "573--574",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - The future of pharmocotherapy for paediatric anxiety

AU - Findling, Robert L

PY - 2002

Y1 - 2002

N2 - There is a growing body of data supporting the use of pharmacological agents in the treatment of paediatric anxiety. The most compelling data exists for the use of selective serotonin re-uptake inhibitors. However, questions the safe and efficacious use of medications with anxiolytic properties still remain. Although the field has progressed in the past several years, it is evident that more research needs to be done in the future.

AB - There is a growing body of data supporting the use of pharmacological agents in the treatment of paediatric anxiety. The most compelling data exists for the use of selective serotonin re-uptake inhibitors. However, questions the safe and efficacious use of medications with anxiolytic properties still remain. Although the field has progressed in the past several years, it is evident that more research needs to be done in the future.

KW - Adolescent

KW - Anxiety

KW - Child

KW - Psychopharmacology

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0035999888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035999888&partnerID=8YFLogxK

U2 - 10.1517/14656566.3.5.573

DO - 10.1517/14656566.3.5.573

M3 - Article

VL - 3

SP - 573

EP - 574

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 5

ER -